Aptorum Group Limited (APM) - News Archive

NEW YORK, July 16, 2025—In a significant move to enhance its position in the biopharmaceutical landscape, Aptorum Group Limited (NASDAQ: APM) has announced a definitive agreement for an all-stock merger with DiamiR Bios...

Aptorum Group’s Strategic Offering Amidst Challenging Revenue LandscapeIn a significant move signaling its commitment to advancing critical biomedical solutions, Aptorum Group Limited has announced a registered direct o...

Aptorum Group Limited, a pioneering NASDAQ-listed clinical stage biopharmaceutical throng, has fostered a business update alongside its financial results for the first six months ending June 30, 2023. With a sprawling p...